Investors in the vulnerable global economy constantly seek the Holy Grail: stocks immune to economic downturns. As the stock markets sway with economic and geopolitical uncertainty winds, finding those rare diamonds can feel like navigating a labyrinth blindfolded.

However, seven solid companies weather the storm amidst the chaos and emerge stronger. Below are seven stocks of resilience, each a beacon of stability and growth in tumultuous times.

Read more to delve into these corporations’ fundamentals, triumphs, and strategies that defy conventional market wisdom. In short, these stocks offer financial returns with peace of mind.

International Seaways (INSW)

International Seaways (NYSE:INSW) delivers a solid bottom-line performance. In Q3 2023, International Seaways reported a net income of nearly $100 million, which is equivalent to roughly $2 per diluted share.

This solid performance suggests the company’s capability to derive profits and breed value.

The company’s EBITDA was $151 million for Q3 and exceeded $800 million over the last 12 months. The consistent growth in net income and EPS reflects International Seaways’ capability to deliver strong results despite adversities in the macroeconomic environment and fluctuations in the shipping market.

International Seaways’ focus on returning value to shareholders can be observed through its healthy dividend yield and share buyback programs. The company offered a combined dividend of $1.25 per share, highlighting its financial standing. These dividends and share buybacks contribute to the total returns, with a 16% plus yield on the average market cap during Q3.

Finally, International Seaways’ low cash breakeven level is a key differentiator that boosts its resilience and ability to generate free cash flow even in challenging markets. With a cash break even for the next 12 months under $15K per day, International Seaways shows its ability to cover its operating expenses and debt obligations with minimal revenue. Hence, this low level is based on various factors, including cost-efficient operations, strategic fleet management, and fixed contracted revenue.

Abbott (ABT)

Abbott’s (NYSE: ABT) strategically accelerated investments during the peak of COVID testing demand, particularly in Research & Development (R&D). These investments led to over 25 new growth opportunities.

Abbott strategically accelerated investments during the peak of COVID testing demand, particularly in research & development. The company announced over 25 new growth opportunities across various segments in the last two years, including new products, indications, and geographic expansions.

There were business-specific investments. These include agreements for biosimilar commercialization in emerging markets, investment in science-based solutions for adult nutrition, new diagnostic tests and instruments, and new product approvals in medical devices.

Sales in the nutrition segment increased by 14% in Q4, with significant growth in pediatric and adult nutrition categories. Established Pharmaceuticals sales grew nearly 9% in the quarter and 11% for the full year, driven by the tailored product portfolios across emerging markets.

Despite seasonal effects on rapid diagnostics, core laboratory diagnostics achieved nearly 10% growth, driven by the success of the Alinity suite. Finally, sales of medical devices grew over 15% in the quarter, with solid performances across various businesses, including diabetes care, electrophysiology, rhythm management, structural heart and neuromodulation.

Pfizer (PFE)

Pfizer (NYSE:PFE) has multiple potential key oncology catalysts in 2024, including the

The Big Pharma and Consumer Goods Landscape: Pfizer, 3M, Procter & Gamble, and Restaurant Brands

Pfizer: Expanding Market Reach with New Approvals

With the recent approval of PADCEV in combination with pembrolizumab and XTANDI for specific cancer types, Pfizer’s addressable population has doubled, signaling a significant expansion in market reach. This development underscores Pfizer’s robust oncology pipeline, hinting at substantial revenue growth driven by the company’s strong focus on therapeutic innovation. Moreover, Pfizer’s diversified portfolio, spanning Vaccines, Anti-Infectives, Internal Medicine, Metabolic Diseases, Inflammation, and Immunology, mitigates risks typically associated with a singular therapeutic area. For example, the company’s work on a 4th-generation PCV vaccine candidate and respiratory vaccine combinations exhibits Pfizer’s commitment to addressing prevalent health concerns beyond oncology, further amplifying its market reach and revenue streams.

Furthermore, Pfizer’s emphasis on cutting-edge science and utilization of AI and digital tools to expedite drug development underscores the company’s continuous effort to introduce new products and maintain competitiveness in the pharmaceutical market. The high R&D budget, one of the industry’s most substantial, further supports Pfizer’s robust pipeline across various therapeutic areas and exemplifies its commitment to pioneering advancements in the healthcare sector.

3M: Strategic Focus on Core Competencies

3M’s strategic priorities include optimizing its portfolio by prioritizing geographies, markets, and products with substantial growth potential. The company’s decision to spin off its Health Care business, Solventum, demonstrates its dedication to core competencies and high-growth segments, aligning its business strategy with future expansion and innovation. Moreover, by appointing experienced leaders to oversee the spin-off process, 3M exhibits a nuanced, strategic approach to unlocking value for customers, care providers, patients, and shareholders.

3M’s emphasis on optimizing product portfolios based on market potential, supply chain complexity, and margins reflects a forward-thinking strategy aimed at driving long-term growth. The identification and exit of low-performing portfolios within the consumer business further underscore 3M’s commitment to enhancing value through strategic portfolio management, highlighting the company’s efforts to refine its business operations for sustained success.

Bolstering its strategic initiatives is 3M’s robust cash flow generation, with a 30% increase in free cash flow and a notable reduction in net debt, indicative of the company’s financial resilience and proactive approach to investment and capital structure management. As 3M prepares for the upcoming spin-off of its healthcare business, the company positions itself to fortify its balance sheet, providing additional liquidity and flexibility to fuel future growth initiatives and meet cash flow needs.

Procter & Gamble: Driving Sales Performance and Market Share Expansion

Procter & Gamble’s focus on accelerating volume growth has yielded promising results, as the company’s volume growth in North America surged from a decline of three points to a robust 4% growth over the past five quarters. This acceleration reflects Procter & Gamble’s ability to capture market share effectively and expand its customer base, underscoring its strong sales performance and competitive positioning in the consumer goods sector.

Furthermore, Procter & Gamble’s global aggregate value share increased by 0.4% year-over-year, with the company’s top 50 category-country combinations maintaining or growing their shares. Notably, the company’s value share in European focus markets rose by 0.9% over three months, collectively pointing to Procter & Gamble’s strong competitive edge and capability to outperform rivals in key markets, in line with the company’s expansion strategy.

Restaurant Brands: Franchise Profitability Centric Strategy

For Restaurant Brands, there has been a remarkable 30% year-over-year increase in home market franchise profitability, reflecting the company’s focus on enhancing the profitability of its franchisees operating in their primary markets. This growth underscores Restaurant Brands’ commitment to supporting and elevating the performance of its franchise partners, as the company positions itself for sustained success through a franchise-centric strategy.

Restaurant Brands International (QSR)

Restaurant Brands International (QSR) has successfully executed meticulous strategies to sharpen its operational prowess and amplify franchise partners’ profitability. The Q4 of 2023 has been pivotal for the company, as evidenced by a remarkable surge in global system-wide sales, soaring nearly 10%, along with a staggering 12% YoY growth for the entire fiscal year. This pronounced growth evinces the company’s adeptness in alluring customers and driving sales worldwide across its sprawling network of franchise locations.

The rapid propulsion in system-wide sales is a testament to the unwavering demand for Restaurant Brands’ brands, including Tim Hortons, Burger King, and Popeyes Louisiana Kitchen. Think of it as a resounding echo reverberating through the edifice of consumer demand.

In addition to the astronomical global growth, the company has also attained a robust comparable sales surge, with a nearly 6% YoY escalation in Q4. Notably, this growth was spearheaded by over 8% at Tim Hortons Canada and over 6% at Burger King US. This remarkable outperformance of key segments underscores the sublime effectiveness of Restaurant Brands’ brand-specific strategies and initiatives tailored to different markets. As a result, these developments are poised to elevate the company’s valuation to mirror the exuberance of its performance.

Kroger (KR)

Kroger’s (NYSE:KR) tenacious ability to allure and retain customers is unequivocally remarkable. The company has accomplished its 10th consecutive quarter of total household growth in Q3 of 2023, marking a consistent expansion in its customer base. This impressive feat can largely be attributed to the efficacy of its loyalty programs and personalized promotions, which have exponentially augmented engagement, with digitally engaged households soaring by 13% in the same quarter. It’s like watching a gardener nurture their plants to bloom, and the bloom is vibrant and irresistible.

The crux of the matter lies in the tangible correlation between engagement and profitability – digitally engaged households spend nearly three times more with Kroger, underscoring the company’s ability to turn engagement into a fertile ground for profitability.

Kroger has judiciously invested in personalized offerings, which, in turn, have translated into soaring engagement and spending, well and truly underpinning its potential for sustained growth.

Delving into the digital realm, Kroger’s digital business has witnessed a resounding surge in both pickup and delivery services, signaling a seismic shift towards online shopping. The efficacy of Kroger’s digital platforms in seizing upon this evolving demand trend is unequivocally glaring, reminiscent of a maestro seamlessly orchestrating a symphony of customer satisfaction.

In a nutshell, with digital sales recording an 11% surge in Q3, riding the wave of increasing consumer adoption of online shopping, and the introduction of novel services like two-hour pickup in one-third of its stores leading to a commendable uptick in sales, it is incontrovertible that these core developments may culminate in a robust valuation potency for Kroger.

As of this writing, Yiannis Zourmpanos held long positions in PFE and MMM. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.